Development and external validation of a psychological stress-related gene signature for overall survival prediction in bladder cancer.
- 1Department of Urology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Abstract
Psychological stress may influence tumor progression through neuroendocrine, inflammatory, immune, and microenvironmental mechanisms, but its prognostic relevance in bladder cancer (BLCA) remains incompletely defined. We aimed to develop and externally validate a psychological stress-related gene (PRG) signature for overall survival (OS) and characterize its biological context. This retrospective study used The Cancer Genome Atlas bladder cancer cohort (TCGA-BLCA; n=404, 176 deaths) for development and Gene Expression Omnibus (GEO) GSE48075/GSE48277 (n=73, 45 deaths) for external validation. Candidate PRGs underwent differential-expression analysis, univariate Cox screening, and least absolute shrinkage and selection operator (LASSO)-Cox modeling. The fixed 23-gene model was evaluated by survival and prognostic-performance analyses. Post hoc analyses assessed functional annotation, clinicopathological subgroups, stress-related pathway scores, immune functional-state and Tumor Immune Dysfunction and Exclusion (TIDE) features, drug-pathway associations, and network-defined hub genes. High-risk patients had worse OS in TCGA (P<0.001) and GEO (P=0.006). Apparent 1-, 3-, and 5-year TCGA areas under the receiver operating characteristic curve were 0.741 [95% confidence interval (CI), 0.679-0.798], 0.742 (95% CI, 0.684-0.800), and 0.774 (95% CI, 0.716-0.831); GEO discrimination was modest. Prognostic associations were directionally consistent across major subgroups without significant interaction. Risk score correlated positively with all six stress-related programs, most strongly extracellular matrix (ECM) organization (rho =0.509) and angiogenesis (rho =0.497; both Benjamini-Hochberg-adjusted P<0.001). High-risk tumors showed higher checkpoint expression, cytolytic activity, T-cell-inflamed scores, and TIDE/exclusion signals. Forty of 54 drug-pathway correlations remained significant after false-discovery-rate correction. MYC, JUN, EGR1, SREBF1, and FOSL1 were the top network hubs; all were prognostic in TCGA after correction, whereas GEO estimates were directionally concordant but not significant after correction. The fixed PRG signature provided research-level prognostic stratification and was associated with stress-related inflammatory, immune, and tumor-microenvironment programs in BLCA. Because external discrimination was modest and the post hoc biological analyses were exploratory, independent prospective and experimental validation is required before clinical use.
Related
- A Pathological Image-Based Pathomics Signature Combined with Clinicopathological Features for Predicting Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma: A Development and External Validation Study
- Development and external validation of an 18-gene tertiary lymphoid structure-related prognostic signature in gastric cancer.
- Admission-time prediction of 7-day mortality in clinician-attributed hypertensive intracerebral hemorrhage: development and external validation against the ICH score
- Development and external validation of a prediction model for suboptimal orthokeratology control in adolescents
- Development and external validation of prediction models for a trial-informed operational composite after stage 3 acute kidney injury
BibTeX
@article{luo2026development,
title = {{Development and external validation of a psychological stress-related gene signature for overall survival prediction in bladder cancer.}},
author = {Pengwei Luo and Jiajun Xie and Rong Kang and Wenjie Deng and Ziyang Zhou and Tailong Zhang and Lei Cheng and Xi Xie},
journal = {Translational andrology and urology},
year = {2026},
month = sep,
doi = {10.21037/tau-2026-0679},
url = {https://europepmc.org/article/MED/42997270},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Development and external validation of a psychological stress-related gene signature for overall survival prediction in bladder cancer.
AU - Pengwei Luo
AU - Jiajun Xie
AU - Rong Kang
AU - Wenjie Deng
AU - Ziyang Zhou
AU - Tailong Zhang
AU - Lei Cheng
AU - Xi Xie
PY - 2026
DA - 2026/09/29
JO - Translational andrology and urology
DO - 10.21037/tau-2026-0679
UR - https://europepmc.org/article/MED/42997270
AB - Psychological stress may influence tumor progression through neuroendocrine, inflammatory, immune, and microenvironmental mechanisms, but its prognostic relevance in bladder cancer (BLCA) remains incompletely defined. We aimed to develop and externally validate a psychological stress-related gene (PRG) signature for overall survival (OS) and characterize its biological context. This retrospective study used The Cancer Genome Atlas bladder cancer cohort (TCGA-BLCA; n=404, 176 deaths) for development and Gene Expression Omnibus (GEO) GSE48075/GSE48277 (n=73, 45 deaths) for external validation. Candidate PRGs underwent differential-expression analysis, univariate Cox screening, and least absolute shrinkage and selection operator (LASSO)-Cox modeling. The fixed 23-gene model was evaluated by survival and prognostic-performance analyses. Post hoc analyses assessed functional annotation, clinicopathological subgroups, stress-related pathway scores, immune functional-state and Tumor Immune Dysfunction and Exclusion (TIDE) features, drug-pathway associations, and network-defined hub genes. High-risk patients had worse OS in TCGA (P<0.001) and GEO (P=0.006). Apparent 1-, 3-, and 5-year TCGA areas under the receiver operating characteristic curve were 0.741 [95% confidence interval (CI), 0.679-0.798], 0.742 (95% CI, 0.684-0.800), and 0.774 (95% CI, 0.716-0.831); GEO discrimination was modest. Prognostic associations were directionally consistent across major subgroups without significant interaction. Risk score correlated positively with all six stress-related programs, most strongly extracellular matrix (ECM) organization (rho =0.509) and angiogenesis (rho =0.497; both Benjamini-Hochberg-adjusted P<0.001). High-risk tumors showed higher checkpoint expression, cytolytic activity, T-cell-inflamed scores, and TIDE/exclusion signals. Forty of 54 drug-pathway correlations remained significant after false-discovery-rate correction. MYC, JUN, EGR1, SREBF1, and FOSL1 were the top network hubs; all were prognostic in TCGA after correction, whereas GEO estimates were directionally concordant but not significant after correction. The fixed PRG signature provided research-level prognostic stratification and was associated with stress-related inflammatory, immune, and tumor-microenvironment programs in BLCA. Because external discrimination was modest and the post hoc biological analyses were exploratory, independent prospective and experimental validation is required before clinical use.
SN - 2223-4691
ER -